Table 1.
Patient demographics and presentation, n=29.
Age | 38 years (IQR 27) |
---|---|
Sex (F:M) | 1.2:1 |
N (Percent) | |
Presenting symptoms | |
– Hearing loss | 11 (37.9%) |
– Lower cranial nerve symptoms | 7 (24.1%) |
– Facial weakness | 4 (13.7%) |
– Pulsatile tinnitus | 4 (13.7%) |
– Bruit | 2 (6.9%) |
– Papilledema | 1 (3.5%) |
– Palpable/fungating mass | 2 (6.9%) |
– Incidental | 1 (3.5%) |
Facial nerve function | |
– Good facial nerve function (HB 1–2) | 25 (86.3%) |
– Poor facial nerve function (HB 3–6) | 4 (13.7%) |
Signs of vagal nerve paresis | 11 (37.9%) |
Functioning tumors | 3 (10.3%) |
Tumor size (greatest axial diameter) | 3.4 ± 1.8 cm |